Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 2.
Published in final edited form as: Structure. 2023 Jan 16;31(3):329–342.e4. doi: 10.1016/j.str.2022.12.011

Conformational exchange divergence along the evolutionary pathway of eosinophil-associated ribonucleases

David N Bernard 1,8, Chitra Narayanan 1,2, Tim Hempel 3,4, Khushboo Bafna 5,9, Purva Prashant Bhojane 5,10, Myriam Létourneau 1,8, Elizabeth E Howell 5, Pratul K Agarwal 6,*, Nicolas Doucet 1,7,*
PMCID: PMC9992247  NIHMSID: NIHMS1861237  PMID: 36649708

SUMMARY

The evolutionary role of conformational exchange in the emergence and preservation of function within structural homologs remains elusive. While protein engineering has revealed the importance of flexibility in function, productive modulation of atomic-scale dynamics has only been achieved on a finite number of distinct folds. Allosteric control of unique members within dynamically diverse structural families requires a better appreciation of exchange phenomena. Here, we examined the functional and structural role of conformational exchange within eosinophil-associated ribonucleases. Biological and catalytic activity of various EARs was performed in parallel to mapping their conformational behavior on multiple timescales using NMR and computational analyses. Despite functional conservation and conformational seclusion to a specific domain, we show that EARs can display similar or distinct motional profiles, implying divergence rather than conservation of flexibility. Comparing progressively more distant enzymes should unravel how this subfamily has evolved new functions and/or altered their behavior at the molecular level.

Keywords: Enzyme dynamics, ribonucleases, antibacterial activity, conformational exchange, CEST, CPMG, NMR relaxation, molecular dynamics simulations, Markov state model, intrinsically disordered proteins

eTOC Blurb

Although proteins rely on atomic-scale motions to promote biological and catalytic function, the evolutionary conservation of dynamic events between structural homologs remains poorly understood. In the current work, Bernard et al. reveal important functional and evolutionary divergent features that govern conformational exchange within structurally homologous eosinophil ribonucleases.

Graphical Abstract

graphic file with name nihms-1861237-f0001.jpg

INTRODUCTION

Evidence supporting the importance of conformational flexibility in protein function has led to the evolution of the structure-function paradigm to encompass the ensemble representation of protein structures 13. Conformational dynamics occurs over a wide range of timescales, ranging from fast side-chain motions to slower loop and domain motions 4,5. These atomic-scale movements facilitate the sampling of conformational substates, which correspond to energy minima in the conformational landscape of proteins 6. Indeed, conformational dynamics occurring on the timescale of the catalytic turnover have been shown to be critical for optimal biological function in a variety of enzyme systems, such as E. coli dihydrofolate reductase 7, cyclophilin A 8, adenylate kinase 9, HIV-1 protease 10, DhlA haloalkane dehydrogenase 11, and bovine RNase A (BtRA) 12,13. Further, mutational perturbations of the observed conformational exchange within functionally important regions were shown to significantly affect catalytic turnover in many of these systems 7,8,12,14. However, understanding substate-transitioning movements remains limited to discrete and often unrelated individual protein systems in the sequence and evolutionary space.

Since they form a continuum, decoupling the individual contributions of structure and dynamics represents one of the major challenges to identify the role of conformational motions in protein function. One way to address this is to comparatively characterize the conformational landscape between structural and functional enzyme homologs. This provides a better understanding of how conservation of conformational dynamics contributes to the observed diversity in biochemical and biological function within an enzyme subfamily. Since pancreatic-type ribonucleases (RNases) share the same structural fold and catalyze the endonucleolytic cleavage of RNA 15,16, they represent an ideal model system to characterize the role of conformational motions in enzyme function (Figure 1). In addition to preserving the core catalytic function of transphosphorylation 15,17, canonical RNase members have been subjected to high rates of evolutionary sequence substitutions 18. This allowed various family members to develop a remarkable diversity of unrelated biological functions that rely on different molecular mechanisms of action 1824. Distinct RNase subfamily members are thus involved in host defense 25, angiogenesis 20,26, neuroprotection 27, vascular homeostasis 28, and digestion 16. Interestingly, while most family members use the same active-site mechanism to cleave RNA substrates with varying levels of affinity and efficiency, their novel biological roles do not always require preservation of RNA cleavage potential 29. Indeed, while ribonucleolytic function is absolutely required for some members of the family to carry out these other biological roles, the core RNA catalytic function also appears purely accessory in other members 16,30. Recent studies have also illustrated the conservation of amino acid networks whose conformational exchange on the millisecond time frame correlates with the rate of enzyme catalysis 31. Further, conservation of global dynamic properties was observed for RNase members grouped into phylogenetic subfamilies, linking unique conformational exchange events to biological function 32.

Figure 1. Overall fold of the pancreatic-type ribonuclease.

Figure 1.

Cartoon representation of human eosinophil-derived neurotoxin (EDN), also known as Homo sapiens RNase 2 (HsR2, PDB entry 1GQV). The characteristic V-shaped kidney structure shows two opposite domains termed V1 and V2, defined by two opposing antiparallel β-sheets formed by strands β2-β3-β6-β7 for V1 and strands β1-β4-β5 for V2 17. Secondary structure elements are annotated, and conserved disulfide bridges are shown in yellow. Catalytic residues His15, Lys38 and His129 are labelled in blue.

Although phylogenetic and conformational clustering provides a measure of their distinct biological roles 32, catalytic and biological functions remain significantly diverse within subfamilies. For instance, human RNase 2 (also known as eosinophil-derived neurotoxin, or EDN), displays potent antiviral 33,34 and chemotactic activities 35, while human RNase 3 (also known as eosinophil cationic protein, or ECP), exhibits cytotoxic 36, helminthotoxic 37, and antibacterial activities 29,38,39. Both RNases 2 and 3 arose as a result of a gene duplication event that occurred when Old and New World monkeys evolutionarily diverged from each other 40. RNase 2 exhibits distinct millisecond conformational exchange and was shown to be nearly 90 times more catalytically active than RNase 3 41.

Despite our current understanding linking the ribonucleolytic function with conformational exchange in distant members of the broad pancreatic-type RNase superfamily 17,32,4244, it remains unclear how phylogenetically close subfamily members have evolved conformational exchange to preserve similar biological function(s). Using closely related members of this subfamily as model systems, we performed systematic characterization of the conformational flexibility, catalytic activity, and biological function of various eosinophil-associated RNases (EARs). In addition to human RNases 2 and 3 (HsR2 and HsR3), we broadened the evolutionary space to include representative orthologs from primates, i.e. RNase 3 from the Bornean orangutan (Pongo pygmaeus, PpR3), Sumatran orangutan (Pongo abelii, PaR3), crab-eating macaque (Macaca fascicularis, MfR3), as well as RNase 2 from the three-striped night monkey (Aotus trivirgatus, AtR2). We integrated NMR experiments (15N-CPMG, 15N-CEST) and molecular dynamics (MD) simulations to quantify the conformational exchange experienced by EARs spanning the nanosecond (ns) to second (s) timescales. We measured kinetic parameters, antibacterial activity against Gram-positive and Gram-negative bacteria, and performed cytotoxicity assays against HeLa cells to characterize and compare the catalytic and biological functions of these enzymes. Our results illustrate greater diversity in the conformational landscape than the diversity in catalytic and biological activities for RNases within this phylogenetic subfamily.

Despite the obvious limitations of comparing flexibility profiles between ligand-free homologs, our results nevertheless demonstrate that conformational exchange is largely concentrated in the V1 domain of evolutionarily related EARs. This contrasts with the conformational exchange profiles observed between structurally similar yet phylogenetically (and functionally) more distant members of the pancreatic-type RNase superfamily 32, further supporting the idea that V1 domain flexibility is functionally preserved in EARs. Our observations also evoke rapid divergence of conformational exchange within the eosinophil-associated RNase subfamily, which may fine-tune the biochemical and biological functions of these enzymes along their evolutionary trajectory.

RESULTS

Phylogenetic analysis

To characterize the evolutionary relationships between the homologous sequences within the RNase superfamily in the context of functional and dynamic comparison, we performed the phylogenetic clustering of RNase sequences from different organisms. Results show classification of the canonical RNases into distinct subfamilies, as shown in Figure 2 and corroborated by earlier studies 21,22,32,45,46. This observation supports the fact that several RNase subfamily clusters diverged before species differentiation, although individual members may still be evolving for specific target functions within species. RNases 2 and 3 diverged only in Old World monkeys, and thus are relatively new genes 24. The owl monkey RNase (AtR2) belongs neither to RNases 2 nor to RNases 3; it is rather an undifferentiated eosinophil RNase. RNase 3 sequences from primates display high sequence similarity, yet the elevated rate at which eosinophil RNases have evolved 23 has made them dissimilar enough to serve as effective models to probe the effect of dynamical variation on their function (Table 1).

Figure 2. Phylogenetic classification of pancreatic-type RNases.

Figure 2.

Multiple sequence alignment of selected members of the RNase superfamily depicted in Figure S1 was used for phylogenetic clustering. Branching of the eight human RNases is identified using distinct colors. Inset shows the branch corresponding to the EAR subfamily. The six RNases characterized in this work (HsR2, HsR3, AtR2, PpR3, PaR3, and MfR3) are indicated using an asterisk in the inset (*).

Table 1. Sequence identity and similarity between RNases investigated in this study.

Sequence identity and similarity scores are given before and after the slash, respectively. Scores were calculated using NCBI BLAST.

BtRA HsR2 AtR2 HsR3 MfR3 PpR3 PaR3
BtRA 35%/46% 34%/46% 28%/45% 27%/41% 28%/44% 30%/42%
HsR2 35%/46% 69%/76% 65%/75% 64%/73% 70%/78% 76%/82%
AtR2 34%/46% 69%/76% 68%/75% 62%/72% 69%/78% 68%/75%
HsR3 28%/45% 65%/75% 68%/75% 86%/92% 85%/91% 74%/85%
MfR3 27%/41% 64%/73% 62%/72% 86%/92% 81%/90% 68%/81%
PpR3 28%/44% 70%/78% 69%/78% 85%/91% 81%/90% 84%/89%
PaR3 30%/42% 76%/82% 68%/75% 74%/85% 68%/81% 84%/89%

Biochemical and biological activities of EARs

The premise for the comparison of simian eosinophil RNases is that their biological activities must be similar amongst each other and to that of their human counterpart. To test this hypothesis, we characterized the catalytic and biological (antibacterial and cytotoxic) activities of the selected RNases. We quantified the endonucleolytic cleavage reaction of EARs using uridylyl-(3′−5′)adenosine (UpA) as substrate, one of the smallest and most characterized consensus dinucleotide sequences (Table 2). This substrate preserves the scissile phosphate subsite (P1) flanked by a pyrimidine base in B1 and an adenine base essential for proper binding to the B2 subsite in RNases 15. For comparison, kinetic parameters of HsR2–3 and the prototypical bovine RNase A (BtRA) were also quantified for reference. While these enzymes can accommodate larger substrates with better affinity due to additional molecular interactions 17, the choice of the UpA dinucleotide substrate facilitates comparison between the different RNases and limits bond cleavage to a single catalytic event per substrate molecule. Results show that all RNases cleave UpA, as expected from canonical members of this superfamily 16. All RNase 3 orthologs exhibit a kcat of ~1 s−1 and a KM of ~1–5 mM, resulting in catalytic efficiencies (kcat/KM) three to four orders of magnitude weaker than that of the prototypical bovine RNase A (BtRA) (Table 2). HsR2 has the highest kcat (~88 s−1) among EARs and a catalytic turnover only 20 times lower than BtRA. As previously reported 24, AtR2 exhibits lower catalytic efficiency than all other EARs.

Table 2. Comparison of the kinetic and biological properties of RNases.

The Michaelis constant (KM) and turnover number (kcat) were obtained using the Michaelis-Menten equation, as described in experimental procedures. The isoelectric point (pI) was estimated using ProtParam on the ExPASy server.

Enzyme pI kcat (s−1) kcat relative to RNase A KM (μM) KM relative to RNase A kcat/KM (M−1s−1) kcat/KM relative to RNase A Antibacterial activity Cytotoxicity

BtRA 8.64 471±26 1 130±35 1.00 3.62*106 1 - -
HsR2 9.20 87.83±3.90 0.186 520±54 4.00 1.69*105 0.047 +/− +
HsR3 10.47 0.97±0.06 0.0021 1230±220 9.46 789 2.18*10−4 ++ ++
MfR3 10.60 1.000±0.142 0.0021 2650±69 20.38 377 1.04*10−4 ++ +
PpR3 10.01 1.28±0.12 0.0027 1380±310 10.62 928 2.56*10−4 + +
PaR3 9.53 Not saturated Not saturated 416 1.15*10−4 + +
AtR2 9.20 0.52±0.10 0.0011 4960±1450 38.15 105 2.90*10−5 - +

While catalytic activity is common to all canonical RNases, RNase 3 orthologs are typically defined by their antibacterial activity, which was shown to be lacking even in RNase 2 47. The antimicrobial activity of EARs, which was particularly well characterized for HsR3, is known to proceed via a mechanism that involves protein anchoring and aggregation at the cell membrane, with subsequent membrane solubilization through a carpet-like mechanism 19,39. In bacteria, amyloid-like protein aggregation was shown to induce cell agglutination, which is essential for the antimicrobial activity of ECP at the cell surface 48. Interactions with outer membrane lipopolysaccharides (LPS) were also shown to play a role in cell agglutination in Gram-negative bacteria 19,49. Interestingly, this molecular mechanism is independent from the ribonucleolytic activity of HsR3 29. We investigated this biological role of eosinophil RNases against both Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus (Figure 3). Our results show that all Old World monkey eosinophil RNase 3 orthologs sharing an elevated pI (HsR3, MfR3, PpR3, and PaR3) cause a dose-dependent reduction in the survival rate of both Gram− and Gram+ bacteria, with a stronger effect against E. coli than S. aureus. HsR3 and MfR3 display the most potent toxicity, with a survival rate lower than 1.1% of the negative control in presence of 5 μM RNase. Other RNase 3 orthologs are less potent, but still efficient, with 28.9% (42.1%) and 40.8% (68.4%) of E. coli (S. aureus) survival at 5 μM PpR3 and PaR3, respectively. Surprisingly, HsR2 displays antibacterial activity against E. coli, leading to a survival rate of 45.2% at 5 μM concentration. We note that the maximal concentration used was greater than the one reported by Rosenberg and Dyer 29, and no antibacterial effect was observed at 2 μM, consistent with their observations. We did however observe a significant increase in the bacterial survival rate (~200% of the negative control) for E. coli incubated with 0.5 μM HsR2. No antibacterial activity was detected for HsR2 against S. aureus. Finally, AtR2 did not significantly affect the survival rate of either bacterial strain, consistent with previous observations 24.

Figure 3. Antibacterial activity of simian eosinophil RNases.

Figure 3.

Normalized counts of colony-forming units (CFUs) of exponentially growing gram-negative E. coli or gram-positive S. aureus incubated for three hours in presence of various amounts of eosinophil RNases. Bovine RNase A (BtRA) was used as a negative control, and human RNase 3 (HsR3) was used as a positive control. Each condition was monitored at least in triplicate. Individual data points are shown as blue scatter plots on each bar graph. Significance was assessed using OneWay ANOVA with * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.

To characterize the cytotoxic effects of RNases, we performed cytotoxicity assays against HeLa cells using increasing enzyme concentrations (Figure 4). To the best of our knowledge, this is the first study reporting the direct cytotoxic effects of these simian RNases against eukaryotic cells. All eosinophil RNases tested decreased HeLa cell survival in a concentration-dependent manner. As expected, RNase A did not alter the ability of HeLa cells to metabolize the Cell Titer Blue assay reagent, while HsR3 significantly reduced cell viability at 50 μM. These results are in accordance with previous observations demonstrating the ability of HsR3 to induce a significant reduction in HeLa cell viability at 20 μM and 40 μM 36. Our results show significant cytotoxicity induced by HsR3, even at 10 μM concentration (Figure 4). Interestingly, while AtR2 did not exhibit antibacterial activity, it is cytotoxic to an extent comparable to that of other eosinophil RNases. The cytotoxic potency observed herein correlates with respective protein pI values, with the highest cytotoxic effects for RNases exhibiting pI values above 10 (HsR3, MfR3, and PpR3), an intermediate response within 9 < pI < 10 (HsR2, PaR3, and AtR2), and no ability to kill HeLa cells (even at 50 μM) for RNase A (pI < 9). These observations are further supported by recent studies evaluating the cytotoxicity of various mouse eosinophil cationic RNases (mEARs), which show that high pI enzymes such as mEAR2 and mEAR5 are the most cytotoxic among all tested mEARs 50.

Figure 4. Cytotoxicity of simian eosinophil RNases.

Figure 4.

A) Viability of HeLa cells as a function of increasing concentrations of simian RNases assessed with the Cell Titer-Blue Cell Viability Assay from Promega. Bovine RNase A (BtRA, black) was used as a noncytotoxic negative control. Results are expressed as percentage of control (non-treated cells) and represent the mean±SEM of at least 3 independent experiments performed in triplicate. B) Close-up view of the dashed rectangle found in panel A.

Conformational exchange behavior of eosinophil RNases

Conformational exchange of the distant loop 1 on the rate-limiting product release step was previously demonstrated to modulate catalytic function in BtRA 44,51. While such a direct link between conformational exchange and catalytic turnover has not been confirmed in other RNases, the presence of concerted motions on functionally relevant timescales was also reported among several human RNases, including HsR2 and HsR3 17,32,43,5254. Here, we characterized the dynamic profiles of inter-species RNases orthologs over motional and functional timescales ranging from nanoseconds (ns) to seconds (s). We performed 15N-CPMG and 15N-CEST NMR experiments to characterize conformational exchange on the relevant catalytic timescale (kcat) (Table 2). CEST experiments, which measure exchange for dynamic events ranging between ~2.5 ms and ~50 ms (kex ~20 to ~400 s−1) 55,56, are used to complement CPMG relaxation dispersion experiments, which measure exchange occurring over the ~300 μs to ~10 ms time frame (kex ~100 to ~3000 s−1) 57. MD simulations were used to probe the ns-μs timescale motions. We also used Markov State Model (MSM) analysis 58 to obtain equilibrium-weighted estimates of the timescale of conformational exchange processes in the simulation ensembles.

Figure 5 shows the three-dimensional distribution of conformational motions on the ns-s timescales with residues experiencing conformational exchange depicted as spheres. Figure 5A illustrates the difference between the two types of analyses performed on the various datasets, i.e., considering the exchanging residue location alone or combining that information with the exchange rate or timescale. A summary of residues experiencing conformational exchange is presented in Tables S3S5. In contrast to other members of the vertebrate RNase superfamily 32, residues undergoing conformational exchange on the CPMG timescale are located primarily in the V1 domain in all eosinophil RNases. These include residues of loop 4 and β-strands 2, 3, 6 and 7 (Figure 5B). Additional exchanging residues are also observed in α-helix 3 of all eosinophil RNases except HsR3, in loop 5 of PpR3, PaR3 and AtR2, and in loop 7 of AtR2. A comparison of the exchange rates (Figure 5B, represented as color gradient) showed similar rates for HsR3, MfR3, PpR3, and AtR2, with a majority of exchanging residues exhibiting kex values ranging between 200 and 500 s−1. A few isolated residues experienced faster exchange rates (yellow spheres) in MfR3 and PpR3. Exchanging residues in HsR2 exhibit faster exchange rates, ranging between 1000–1400 s−1, consistent with the higher kcat of this enzyme relative to other eosinophil RNases. PaR3 exchanges on a broader range (500–1900 s−1), with no apparent clustering of residues sharing similar kex. Most of the residues identified as undergoing conformational exchange using CEST (Figure 5C) were also observed as undergoing conformational exchange on the slower end of the CPMG timescale (Figure 5B), consistent with their overlapping time range. This network of interconnected residues are clustered in the V1 domain of AtR2, HsR3, MfR3, and PpR3. The lack of residues experiencing conformational exchange on the CEST timescale in HsR2 and PaR3 is consistent with the faster kex values determined from CPMG relaxation dispersion experiments.

Figure 5. Conformational exchange experienced by simian eosinophil RNases.

Figure 5.

Subpanel A depicts the two different analysis methods used to characterize conformational exchange within each RNase, using HsR3 15N-CPMG data as an example. The left panel depicts exchanging residues as grey spheres to highlight their location, whereas the right panel includes the exchange rate. Residues undergoing conformational exchange are represented as spheres and were identified using dual fits of 15N-CPMG relaxation dispersion NMR data (B - first column), 15N-CEST experiments (C - second column), and Markov State Model analysis implied timescales (D - third column). Catalytic residues are depicted as sticks. In B and C, exchanging residues are colored according to the exchange rate kex, whereas residues are colored according to the implied timescale of the exchange process in D. The magnitude of kex values and implied timescales are represented using the color gradient legends on the bottom. Residues whose fits give a kex with a standard deviation larger than the actual value are depicted as black spheres. Black loops correspond to unassigned residues due to line broadening in the NMR spectra. Only residues with an implied timescale slower than 50 ns (see STAR Methods) are depicted as spheres in the third column. Representative curves for each technique are displayed in Figures S5 and S6.

We also characterized the ns-μs timescale motions by determining MSM timescales or decorrelation times of backbone and side-chain torsion dynamics from the MD ensembles for the different eosinophil RNases, in an effort to tease out comparably slow, metastable dynamics rather than fast, thermal fluctuations. Figure 5D shows residues experiencing conformational exchange on the ns-μs timescale as spheres on the three-dimensional structure of the six eosinophil RNases. Exchanging residues vary in number and location across the different RNases. HsR3 and HsR2 displayed the largest (65) and the smallest (26) number of exchanging residues, respectively. Residues of loop 4 experience conformational exchange in all RNases except MfR3, which showed no exchange in this region on the faster timescale. The maximum likelihood estimates of loop 4 motion timescales were observed to span from 60–100 ns for PaR3 (fastest) to 100–750 ns for PpR3 (slowest). Conformational exchange was also observed to varying extents for residues of loop 6 across the different RNases, most noticeably in MfR3, with many residues exchanging on a timescale neighboring ~850 ns.

We further determined the structural changes associated with exchange observed from the MSM analysis. Briefly, MSM implied timescales describe relaxation times of molecular exchange processes. As implied timescales are derived from the eigenvalues of the MSM transition matrix, the corresponding eigenvectors describe the structural process that gives rise to a specific implied timescale 59. Therefore, exchange processes can be uniquely identified in terms of their structures 60, and be depicted by drawing representative frames (e.g., of minimum and maximum of the eigenvector) from the MD simulation. Figure 6 shows a noteworthy process for His82, a residue in the V2 β-sheet known to be essential for substrate binding in the B1 subsite of HsR2 and HsR3. Our results show that rotamer dynamics is conserved for all eosinophil RNases, as this applies to the structurally equivalent Tyr82 in all other eosinophil RNases (AtR2, PaR3, PpR3, and MfR3). Additionally, we identified an exchange phenomenon on the 0.1-to-1 μs range in a cryptic pocket between α1, α2 and β1 at conserved residue Phe43. However, this event was only observed for AtR2 and HsR3, pointing towards a pattern that was not evolutionarily conserved. We note that due to limited sampling, the MSM analysis is restricted to characterizing single residue dynamics on the ns-μs timescale in only one of potentially many large-scale metastable protein conformations. While our sampling is too sparse to predict slower timescale motions or provide high confidence timescales (Figure S7), our analyses indicate convergence of the per-residue MSM implied timescales for all RNases.

Figure 6. Examples of residue dynamics experienced on the 100-ns timescale.

Figure 6.

A) Overall structure of HsR3 showing locations of amino acids analyzed in subsequent panels. B-C) Representative structures of MSM metastable states illustrating between which structures the identified exchange process occurs (left) at positions 82 (B) and 43 (C). In both panels, MSM implied timescales (right) indicate the relaxation time corresponding to that process, resolved for the different eosinophil RNases. Confidence intervals (shaded areas) are computed from Bayesian sampling of the posterior 80. In panel B, two rotamers of His82 (in HsR2, HsR3 [shown structure], PpR3, and MfR3) or Tyr82 (in AtR2 and PaR3) (located on β4) are configurations between which the MSM exchange process occurs. It can be observed in all investigated RNases. In panel C, Phe43 (on β1, embedded between α1 and α2) is conserved in all RNases but shows conformational exchange on the 100-ns regime only for AtR2 and HsR3. Structure renders were created with VMD 81.

Quantitative characterization of conformational exchange properties of eosinophil RNases

A comparison of the location of residues undergoing conformational exchange revealed qualitative similarities in the dynamical patterns of eosinophil RNases on the catalytically relevant timescales (Figure 5). To quantitatively characterize this similarity in the conformational exchange profiles, we calculated the pairwise cosine similarity between all RNases (Figure 7). The conformational exchange profile for bovine RNase A (BtRA), determined previously from CPMG experiments 13, was used for comparison with eosinophil RNases. Characterization of the pairwise cosine similarity between the different RNases showed higher similarity between HsR3, MfR3, PpR3, and AtR2, with the cos(θ) ranging from 0.583 to 0.730 on the CPMG timescale (Figure 7A, left panel). PaR3 displayed a cos(θ) of ~0.45 with other eosinophil RNases, even though most of its exchanging residues are located in the V1 β-sheet like other eosinophil RNases. HsR2 and BtRA displayed the lowest cosine similarity scores with other RNases, highlighting the distinctly different exchange profiles of these enzymes relative to other RNases.

Figure 7. Pairwise comparison of eosinophil RNase exchange profiles.

Figure 7.

Pairwise cosine similarity values for location (left panels) and exchange timescale (right panels) calculated based on comparison of residues along the consensus sequence, color-coded based on strong (white) to weak (dark) similarity. Pairwise cosine similarity values are shown for A) 15N-CPMG, B) 15N-CEST, and C) MSM implied timescales.

A comparison of the cosine similarities based on the magnitude of the exchange rates (kex) showed smaller values, approaching 0, highlighting a lack of similarity of the exchange rates between RNases (Figure 7A, right panel). Among RNases that displayed exchange on the CEST timescale (Figure 7B, left panel), highest similarities were observed between HsR3, MfR3, and PpR3 (between ~0.55 and ~0.7). HsR2 showed lowest correlations with other RNases. No correlations were observed involving PaR3, which showed no exchange on the CEST timescale. A comparison of the exchange timescales (Figure 7B, right panel) showed a similar trend as that observed for residue locations, albeit with small variations in the similarity scores. The cosine similarity values are smaller for most pairwise comparisons, with similarities > 0.5 observed between only three enzyme pairs (AtR2 with HsR3, HsR3 with MfR3, and MfR3 with PpR3), suggesting a diversity in the conformational exchange profiles on this timescale. On the ns-μs timescale probed by MSM analyses, similarities between the location of the metastable dynamics (Figure 7C, left panel) vary between ~0.25 and ~0.67. A comparison of the magnitude of the timescales lowers the similarity values down to at most 0.578, going as low as 0.086 for the MfR3-PpR3 pair (Figure 7C, right panel). This once again corresponds to a lack of similarity for the exchange on this timescale. Overall, more enzymes tend towards dissimilarity with their homologs than the reverse, and this holds true at all timescales.

Characterizing the amplitude of atomic fluctuations on the ns-μs timescale

We characterized the amplitude of conformational fluctuations on the faster timescale by computing the root mean square fluctuations for the top ten modes (RMSF10) from molecular dynamics simulation trajectories as a function of the consensus sequence. A comparison of the RMSF10 of Cα atoms for the six eosinophil RNases (Figure 8A) showed qualitative similarity in the dynamical patterns for all members of this subfamily on the faster timescale, consistent with previous observations 32. Large fluctuations were observed in loop 4 (consensus positions 57–70), loop 6 (consensus positions 88–96) and loop 7 (consensus positions 114–124), in addition to the N- and C-terminal regions. Interestingly, AtR2, the undifferentiated member of this subfamily, showed additional fluctuations in the loop 1 region (consensus positions 17–22). To quantitatively characterize the similarity between the eosinophil RNase sequences, we calculated the pairwise Pearson’s correlation coefficients between the different members (Figure 8B). Our results showed average correlations between eosinophil RNases of 0.7±0.1, similar to previous observations 32. Large correlations were observed between most eosinophil RNases, with the exception of MfR3, which showed the smallest correlations with other RNases.

Figure 8. Amplitude of atomistic fluctuations on the ns-μs timescale.

Figure 8.

A) Root mean square fluctuations as a function of the consensus sequence for members of the eosinophil associated RNases. The calculated RMSFs represent the Cα displacements of the top ten quasi-harmonic modes of eosinophil RNases. The consensus residue numbering represents the indexing that includes gaps, corresponding to insertions/deletions, in sequences. B) Pairwise Pearson’s correlation coefficients for the eosinophil RNases calculated based on comparison of RMSF10 values for each of the positions without an insertion/deletion in any of the six RNases.

Intrinsically disordered regions within eosinophil RNases

Although EARs adopt the well-defined structural fold of pancreatic-type RNases, a large class of other biologically active proteins are known to act in a completely disordered fashion or contain intrinsically disordered regions (IDRs) that play important biological roles in the cell 61. Due to the structural requirements of catalysis, enzymes have long been considered an exception to the IDR rule. Even though the active sites are highly ordered, enzymes also retain functionally important regions (especially the surface loops), which sample multiple conformations resembling the IDRs and intrinsically disordered proteins (IDPs). The function of IDRs and IDPs relies heavily on sampling of the conformational landscape, including the functionally relevant conformations, which is also the case for surface loops in proteins such as EARs. Therefore, conformational flexibility and intrinsic disorder represents an important foundation of the protein structure-function continuum model 61. To investigate whether our conformational exchange analysis specifically correlates with IDRs in eosinophil RNases, we used the IUPred2 server to generate and compare their disorder profiles (Figure S8) 62,63. Except for N- and C-terminal regions (which include unstructured leader sequences), the disorder prediction score correctly highlights the ordered nature of these small globular proteins. Most of the profiles indicate that EARs have few regions of disorder; however, as noted before, there is some degree of correlation between the loops showing high conformational flexibility and disorder 64. Furthermore, at the family level, the conservation of dynamical surface loops is similar to the preservation of disordered regions in families of IDRs and IDPs, further indicating that both flexibility and disorder are a part of the protein structure-function continuum model.

DISCUSSION

The importance of conformational exchange in enzyme function has been illustrated for a variety of model systems 79,13,6567. While these studies demonstrated the role of conformational motions on the function of discrete enzymes, they pertain to proteins that are distant in the sequence space, and thus do not account for the diversity or similarity of conformational profiles observed between evolutionarily closer members within protein families. Other studies have attempted to address this by probing the conformational properties of homologous sequences within protein families 32,68,69. Enzymes clustered into phylogenetic subfamilies that share similar biological functions were shown to display conservation of dynamical properties 32. However, these observations still do not account for the notable differences in the function observed between members within phylogenetic subfamilies. Identification of factors driving this difference in function will provide insights into the evolutionary trajectory of these enzymes. To characterize the role of conformational exchange on evolutionary divergence, here we determined the catalytic, biological, and dynamical properties of six members of the eosinophil RNase subfamily using a combination of biochemical, biophysical, and computational approaches. To the best of our knowledge, this is also the first study reporting on the molecular, dynamical, and functional characterization of eosinophil homologs from Macaca fascicularis (MfR3), Pongo pygmaeus (PpR3), Pongo abelii (PaR3), and Aotus trivirgatus (AtR2).

Eosinophil RNases form one of the subfamilies of pancreatic RNases and include human RNases 2 (EDN) and 3 (ECP), which evolved as a result of a gene duplication event after the divergence of Old World monkeys 47. A comparison of their catalytic activities shows that HsR2 exhibits significantly higher affinity for the UpA substrate and is >80 times more catalytically active than all other eosinophil RNases (Table 2). Previous studies reported distinct antibacterial activities between human and owl monkey eosinophil RNases 24. Our results further revealed a correlation between antibacterial activities and protein charge. RNases with a pI > 10 display the largest antibacterial activities, while RNases with pI between 9 and 10 exhibit lower activities (Figure 3). Further mutagenesis experiments are necessary to confirm this charge dependence on antibacterial activity. All eosinophil RNases exhibit cytotoxic activities against HeLa cells (Figure 4), in line with previous observations on human HsR2 and HsR3 36. These results indicate that cytotoxic activities of eosinophil RNases do not maintain the charge-dependent gradient in activity observed with antibacterial assays.

We characterized the timescale and amplitude of conformational motions sampled by eosinophil RNases over the ns-s timescales by combining observations from MD simulations, in addition to NMR 15N-CPMG and 15N-CEST experiments. Consistent with previous reports 17,32, our results show that eosinophil RNases preserve 3D location similarities for residues undergoing conformational exchange on the functionally relevant μs-ms catalytic timescale (Figure 5A and 5B). In contrast to other members of the RNase superfamily 32, this 3D localization largely correlates with the V1 domain (Figure 1), suggesting evolutionarily pressure to maintain conformational exchange within this domain to preserve biological function(s) promoted by EARs. A comparison of conformational exchange timescales illustrates differences in exchange profiles for HsR2 and PaR3. Residues of AtR2 and all other RNases 3 (except for PaR3) that displayed slower conformational exchange in CPMG measurements were complemented by similar observations from CEST measurements on the ms-s timescale (Figure 5C). Quantitative characterization of the similarity in the conformational exchange patterns between the eosinophil RNases showed higher cosine similarity scores for AtR2 and all RNases 3 (except for PaR3), while HsR2 displayed the largest variations relative to other RNases (Figure 7). Similar trends with diminished similarity scores were observed from CEST experiments, with the exception of PaR3, which showed no exchange on this timescale. Characterization of the faster ns-s timescale motions using MSM analysis also highlighted distinct exchange profiles for the different eosinophil RNases. A comparison of the amplitude of conformational motions showed higher similarities between eosinophil RNases, consistent with previous observations 32.

Our results also illustrate that higher pairwise cosine similarity scores between RNases (Figure 7) do not correlate with the proximity in the evolutionary tree of eosinophil RNases (Figure 2). This is best exemplified by AtR2, the undifferentiated eosinophil RNase. AtR2 shares a higher cosine similarity with RNases 3 on all timescales relative to PaR3, a post-differentiation enzyme. In addition, cosine similarity scores between HsR2 and other eosinophil RNases were just as low as that between these enzymes and BtRA, which diverged early in the evolutionary tree (Figure 2). These results hint at a rapid divergence of conformational exchange patterns, in contrast to a strict conservation along the evolutionary pathway. Such divergence has been described previously, albeit on much more evolutionarily distant enzymes 70. Our observations may also suggest a potential limitation of the analysis, which compares similarity across each consensus residue position, and is not sensitive to any similarities that may arise from the comparison of through-space amino acid networks.

Current observations are obviously limited by the fact that the present study was conducted on the ligand-free EARs in similarly controlled in vitro experimental conditions. Not only is the physiologically crowded molecular environment within eosinophils expected to influence protein dynamics, but prior work on pancreatic-type RNases also demonstrated significant changes in conformational profiles upon ligand binding 71. Additionally, selected EARs may have evolved distinct conformational behavior in the context of specific substrates or molecular targets that would undoubtedly influence their dynamic behavior. Further studies are necessary to investigate the effect of molecular perturbations and ligand binding on the coupling between conformational exchange and biological function within individual EAR members. Nevertheless, the extent to which eosinophil RNases are subjected to conformational exchange may be linked to the rapid molecular evolution of members within this enzyme subfamily 23. Indeed, proteins undergoing extensive conformational exchange have been shown to also possess high evolvability, defined by “the ability to rapidly adopt (within a few sequence changes) new functions within existing folds” 72. Following this definition, evolvability is hard to evaluate without recourse to extensive mutagenesis.

Another feature of highly evolvable enzymes is the ability to perform more than one reaction with a weak efficiency relative to specialized enzymes of the same fold that catalyze the same reactions 73. Numerous examples of such highly flexible, generalist enzymes have been reported, primarily through the characterization of the mechanisms allowing successful protein engineering 67,7378. Our observations for AtR2 show a larger number of exchanging residues at all timescales than all other eosinophil RNases investigated, while at the same time exhibiting lower chemical and biological activities. These two properties are associated with enzyme evolvability, suggesting that these motions may be necessary to preserve function. Subsequent evolution from an undifferentiated protein that might be similar to AtR2 could have led to the ‘freezing out’ of some unproductive motions to give rise to the conserved clusters found in simian RNases 3. Similarly, simian RNases 2 may have evolved independently to acquire their antiviral activity, and the larger number of ‘frozen out’ unproductive motions might have led to the increase in activity relative to other eosinophil RNases. The immune system being in a constant arms race with rapidly evolving pathogens such as viruses, bacteria, and other parasites, it must be able to adapt for species to carry on over the course of evolution 79. High evolvability is thus a desirable feature for host defense proteins such as eosinophil RNases.

In conclusion, individual side-chain nanosecond fluctuations as well as clusters of residues exchanging on slower timescales (μs-s) seem to be conserved within eosinophil RNases sharing chemical and biological functions, but the specifics of the large-scale movements on all timescales investigated tend towards rapid divergence rather than conservation. Our results show how enzymes from the eosinophil RNase subfamily retain flexibility throughout evolution, and how these movements change from one member to the next, thus providing a possible mechanism by which they remain adaptable towards targets which are themselves changing rapidly. We thus demonstrate how rapidly conformational fluctuations can differ between closely related proteins.

STAR METHODS

RESOURCE AVAILABILITY

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Nicolas Doucet (nicolas.doucet@inrs.ca).

Materials availability

Plasmids generated in this study are available upon request.

Data and code availability

All NMR chemical shift assignments for MfR3, PpR3, PaR3, and AtR2, including Cα and Cβ resonances, were deposited in the in the Biological Magnetic Resonance Bank (BMRB) (http://www.bmrb.wisc.edu) under accession numbers 27542, 27544, 27545, and 27546, respectively.

This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

EXPERIMENTAL MODEL AND SUBJECT DETAILS

Cell lines

Human cervix adenocarcinoma HeLa cell line was acquired from ATCC (American Type Culture Collection). It was grown in MEM medium supplemented with 10% FBS, as recommended by the supplier. Cells were maintained at 37°C in a humidified atmosphere of 5% CO2. When confluence reached ~80%, a 1:4 subcultivation ratio was used to inoculate new growth flasks.

Method Details

Phylogenetic analysis

Pancreatic-type RNases comprising hominid, bovine, and mouse sequences, were selected for the analysis. A list of all sequences is provided in the supporting information (Table S1). Multiple sequence alignment of selected sequences was performed using ClustalΩ 83. The phylogenetic tree was inferred using the maximum likelihood approach implemented in PhyML 88 and the JTT substitution model. Reliability of the internal branches was estimated using aLRT test (SH-like) 90. The phylogenetic tree was visualized using FigTree v1.4.2 [http://tree.bio.ed.ac.uk/software/figtree/].

Protein expression, refolding, and purification

Unlabeled bovine RNase A (BtRA) was purchased from BioBasic (Markham, ON, Canada). The human RNase 3 (HsR3) gene was produced as previously described 43. E. coli codon-optimized genes of Macaca fascicularis RNase 3 (MfR3, UniProtKB entry P47779), Pongo pygmaeus RNase 3 (PpR3, P47781), Pongo abelii RNase 3 (PaR3, H2NKI8) and Aotus trivirgatus RNase 2 (AtR2, O18937) were synthesized by ATUM (Newark, CA, USA) and cloned into pJexpress 414 vectors. Unlabeled, 15N- or {13C, 15N}-labeled protein samples were produced as described previously 91, with the following changes. After induction with IPTG, bacterial cultures were grown overnight at 30°C and the refolding step was performed at pH 9.1 for HsR2 and AtR2. Identical purification fractions were identified by circular dichroism. Protein concentration was determined using extinction coefficients of 17,460; 17,460; 14,940; 11,960; 13,450; and 13,450 M−1cm−1 for HsR3, HsR2, MfR3, PpR3, PaR3, and AtR2, respectively, as estimated by Expasy ProtParam.

Steady-state kinetics

Steady-state kinetics data were obtained on a PerkinElmer λ35 UV-Vis spectrophotometer (Waltham, MA, USA). RNase activity was measured in a 50 mM sodium acetate buffer containing 1 mM EDTA at pH 5.5 and 25°C. Dinucleotide substrate UpA was obtained from Dharmacon at GE Healthcare (Lafayette, CO, USA). The concentration of UpA was measured using an extinction coefficient of 24,600 M−1cm−1, as supplied by Dharmacon. Change in UpA absorbance was measured in 1- or 2-mm path length cuvettes at 286 nm for 10 min. Enzyme and substrate concentrations used are indicated in Table S2, and all measurements were performed in duplicate. Water was incubated with 1% DEPC for 1 h and autoclaved. All instruments used were cleaned with DEPC-treated water before initiating the experiment to inhibit environmental contaminant RNases from interfering with the kinetic assays. Buffer was prepared using DEPC-treated water. The data were fitted to the Michaelis-Menten equation using SigmaPlot.

Antibacterial assays

Escherichia coli DH5α strain (Gram-negative) and Staphylococcus aureus Newman strain (Gram-positive) bacteria were grown to mid-exponential phase and resuspended in 10 mM sodium phosphate buffer at pH 7.4. Bacteria were then incubated at 37°C for three hours in the presence of 0.5, 2.0, or 5.0 μM bovine RNase A (BtRA), HsR3, MfR3, PpR3, PaR3, AtR2, or HsR2, each performed in triplicate 38,92,93. BtRA was used as a non-bactericidal enzyme (negative control), while HsR3 was used as positive control 40,92. Bacterial suspensions were then diluted and plated as 4 × 20 μL droplets on LB-agar plates as per the Miles-Misra technique 94, and allowed to grow overnight at 37°C. Colony-forming units (CFU) were then counted the following day.

Cytotoxicity assays

Culture of the human HeLa cell line was achieved using DMEM supplemented with 10% Foetal Bovine Serum (FBS) as culture media. HeLa cells were seeded in 96-well plates at a density of 50,000 cells/well and incubated overnight at 37°C. Cells were then serum deprived for 2 h prior to RNase treatment performed in serum-free culture media with a final volume of 100 μL per well. Cells were treated with RNases at concentrations ranging from 0 to 10 μM for 48 hours. Cell viability was then evaluated using the Cell Titer-Blue Assay from Promega (Madison, WI, USA) following the supplier’s protocol. Data were recorded on a Tecan Infinite M1000 Pro microplate reader (Männedorf, Switzerland) set at 560 nm and 590 nm for excitation and emission wavelengths, respectively. Results were expressed as percentage of control (non-treated cells) and represent the mean±SEM of at least 3 independent experiments performed in triplicate.

Solution NMR experiments

NMR spectra were recorded at 298 K on 100–400 μM protein samples in 15 mM sodium acetate buffer, pH 5.0, and 10% 2H2O. All spectra were performed on a Varian INOVA spectrometer (Palo Alto, CA, USA) at a working 1H frequency of 500 or 800 MHz (MfR3 and PpR3), or on a Bruker Avance III spectrometer (Billerica, MA, USA) at a working 1H frequency of 600 MHz (equipped with a 5 mm TCI cryoprobe) or 800 MHz (equipped with a 5 mm TXI probe) (PaR3 and AtR2). 2D {1H, 15N}-HSQC, 3D-HNCACB, 3D-CBCA(CO)NH assignment experiments were performed for all nonhuman proteins. Chemical shift resonance assignments are presented in Figures S2S3 for 2D {1H, 15N}-HSQCs and have been deposited in the Biological Magnetic Resonance Bank (BMRB) (http://www.bmrb.wisc.edu) under accession numbers 27542 (MfR3), 27544 (PpR3), 27545 (PaR3), and 27546 (AtR2). Relaxation-compensated 15N-Carr-Purcell-Meiboom-Gill (15N-CPMG) dispersion experiments 95 were recorded in an interleaved fashion with τcp delays of 0.625, 0.714 (x2), 1.25, 1.667, 2.0, 2.5 (x2), 3.333, 5.0, and 10.0 ms, using a total relaxation period of 40.0 ms, as described earlier 13,42,43. 15N-Chemical Exchange Saturation Transfer (15N-CEST) experiments 55 were performed using 15 and 25 Hz B1 irradiation fields. Series of 114 to 124 2D datasets were acquired, corresponding to 15N offsets interspaced by 0.25 ppm (~20 Hz) that span the whole resonance array of each analyzed protein and for both B1 fields. All spectra were processed using NMRPipe 87, and peak picking was performed using CcpNmr AnalysisAssign 84 and Sparky [T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco, https://www.cgl.ucsf.edu/home/sparky/]. 15N-CPMG-derived R2,eff values were fitted to the full single-quantum CPMG equation 57,96 using GraphPad Prism. 15N-CEST intensity profiles were analyzed using the Chemex scripts [https://github.com/gbouvignies/chemex; 55].

NMR chemical shift assignments of the four simian eosinophil RNases

To determine the atomistic behavior of the various eosinophil RNases, we assigned chemical shifts of protein backbone atoms using {1H, 15N}-HSQC, HNCACB, and CBCA(CO)NH heteronuclear NMR experiments. All HSQC spectra (Figures S2S3) show well-dispersed resonances, indicating well-folded proteins. Assigned non-proline backbone amides of each protein amounted to 120 out of 121 (MfR3), 121 out of 122 (PpR3), 115 out of 121 (PaR3), and 118 out of 121 (AtR2) resonances identified. All chemical shift assignments for MfR3, PpR3, PaR3, and AtR2, including Cα and Cβ resonances, were deposited in the BMRB under accession numbers 27542, 27544, 27545, and 27546, respectively. Due to resonance line broadening, we note that residues from the putative loop 5 (Ser74 to Val78) could not be assigned in PaR3, suggesting exchange on the intermediate regime for this loop. This is further supported by the observed weakness in signal amplitude for upstream residues His72 and His73 in PaR3. Similarly positioned residues Cys71, His72, His73, and Ser74 in AtR2, or Gly75, Ser76, and Gln77 in HsR2, show analogous behavior 52,53. Since both AtR2 and HsR2 share a single residue difference with the homologous loop 5 of PaR3, this observation is consistent with a similar exchange regime.

Homology modeling

Structures of simian RNases PpR3, PaR3, MfR3, and AtR2 were determined through homology modeling using MODELLER v9.13 with human RNases 2 (PDB entry 1GQV) and RNase 3 (PDB entry 1QMT) structures as templates. The four simian RNase sequences share high sequence identities with human RNases 2 and 3 (Table 1). Models were generated using the automodel option and structures with the lowest DOPE scores for each enzyme were selected for each of the four enzymes.

Computational simulations and analyses

Crystal structures of human RNases 2 and 3 (PDB entries 1GQV and 1QMT, respectively) were used as starting structures. For other RNases with no available crystal structures, homology models were used as initial coordinates (see above). We validated our models by comparing NMR 15N chemical shifts with the computationally derived ones using the CS2BACKBONE module of PLUMED 2.4.4 89, as shown in Figure S4. All simulations were performed using the graphical processing unit (GPU) enabled version of AMBER 82 v14 (pmemd program) and the ff14SB force field. Each enzyme was placed in a rectangular box with SPC/E water and neutralized through the addition of counter ions. The minimum distance between the enzyme and box edge was set to 10 Å. System equilibration, comprising a series of energy minimization and equilibration steps, was performed at 300 K using the protocol described previously 32,97. Simulations were performed using timesteps of 2 fs under constant energy conditions (NVE) with periodic boundary conditions. Long-range electrostatic interactions were computed using the particle mesh Ewald (PME) method and a cut-off of 8 Å. All simulations were performed for a total of 1 μs for each enzyme. Root mean square fluctuations of the top ten modes (RMSF10) was calculated using the trajectory (conformations) obtained for each enzyme using the CPPTRAJ program [https://github.com/Amber-MD/cpptraj]. Translational and rotational diffusion of individual structures was removed by superposing all structures within a trajectory to a reference.

Markov State Model (MSM)

MSM analysis 59,98100 was performed to estimate the conformational exchange timescales using PyEMMA 58. For each residue, we computed backbone and side-chain torsion angles and used them separately as input features for per-residue MSMs 101. We thereby assume that the degrees of freedom that govern the motions of the single amino acids are defined by their constant local environment such that larger scale protein motions are negligible for the timescales derived here. The continuous angle trajectories per residue were discretized with 150 cluster centers (k-means clustering) to obtain time series of discrete states. The connection between changes of torsion angles and MSM implied timescales is exemplified in Figure S6. Model validation was performed by comparing results for different numbers of discrete states (50, 100, 150) and by ensuring implied timescale convergence. Hidden Markov Models (HMMs) that fulfilled these measures were manually selected to estimate the implied timescales presented below. Model estimation was performed at a lag time of 10 ns.

Cosine similarity comparisons

Cosine similarity comparisons were performed using the above sequence alignments for the dimensionality, residue-dependent parameters extracted from NMR experiments, or MSM analyses as the vector components, and the following formula:

cosθ=ABAB=i=0NAiBii=0NAi2i=0NBi2

This technique uses a vector representation of each protein, with a dimensionality equal to the number of positions in the consensus sequence (134 when comparing only eosinophil RNases, 140 when accounting for RNase A). The consensus sequence represents an indexing corresponding to the multiple sequence alignment of RNases that includes gaps representing insertions/deletions in sequences and facilitates easier comparison of sequences of different lengths. The value of any residue-dependent parameter can be used as the vector components. Calculating the cosine of the angle θ between these vectors (cos(θ)) through a dot product thus gives an easily obtainable quantitative way to compare proteins, with values close to 1 (i.e., parallel vectors) corresponding to similar proteins. To clarify these comparisons, the effects of location and exchange rate have been bisected. For pairwise comparison of the exchanging residue location, we used a binary encoding (1 or 0) for exchanging and non-exchanging (or alignment gap) residues as they are identified by CPMG and CEST experiments as well as MSM analyses. Residue-specific kex values obtained either from CPMG or CEST and MSM-implied timescales were then directly compared to assess timescale magnitudes.

QUANTIFICATION AND STATISTICAL ANALYSIS

All statistical analysis and software used can be found in the figure legends and method details. For cytotoxic and antibacterial assays, statistical tests used are expressed as percentage of control (non-treated cells). They represent the mean ± SEM of at least 3 independent experiments performed in triplicate. Significance was assessed using OneWay ANOVA with * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.

Supplementary Material

1

KEY RESOURCES TABLE.

REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and virus strains
Escherichia coli BL21(DE3) cells
Genotype: F(-) ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])
BCCM/GeneCorner, obtained from the lab of Eric Déziel (INRS) Cat#LMBP1455,https://bccm.belspo.be/catalogues/genecorner-host-details?NUM=LMBP%201455
Escherichia coli DH5α cells
Genotype: supE44 ΔlacU169 (φ80 lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1
DSMZ (German Collection of Microorganisms), obtained from the lab of Eric Déziel (INRS) Cat#DSM6897, https://www.dsmz.de/collection/catalogue/details/culture/DSM-6897
Staphylococcus aureus Newman strain ATCC, obtained from the lab of Eric Déziel (INRS) Cat#25904, https://www.atcc.org/products/25904
Chemicals, peptides, and recombinant proteins
Bovine RNase A (BtRA) BioBasic RB0473
Deposited data
Aotus trivirgatus RNase 2 (AtR2) This paper Biological Magnetic Resonance Bank (BMRB) entry 27546
Macaca fascicularis RNase 3 (MfR3) This paper Biological Magnetic Resonance Bank (BMRB) entry 27542
Pongo abelii RNase 3 (PaR3) This paper Biological Magnetic Resonance Bank (BMRB) entry 27545
Pongo pygmaeus RNase 3 (PpR3) This paper Biological Magnetic Resonance Bank (BMRB) entry 27544
Experimental models: Cell lines
Human HeLa cells ATCC CCL-2, https://www.atcc.org/products/ccl-2
Oligonucleotides
UpA dinucleotide Dharmacon/GE Healthcare N/A
Recombinant DNA
Homo sapiens RNase 3 (HsR3) 43 N/A
Aotus trivirgatus RNase 2 (AtR2) ATUM GeneID 150351
Macaca fascicularis RNase 3 (MfR3) ATUM GeneID 150353
Pongo abelii RNase 3 (PaR3) ATUM GeneID 150355
Pongo pygmaeus RNase 3 (PpR3) ATUM GeneID 150354
Software and algorithms
AMBER 14 82 https://ambermd.org/
ClustalΩ 83 https://www.ebi.ac.uk/Tools/msa/clustalo/
CcpNmr AnalysisAssign 84 https://ccpn.ac.uk/software/
Chemex 55 https://github.com/gbouvignies/chemex
CPPTRAJ 85 https://github.com/Amber-MD/cpptraj
ESPript 3.0 86 https://espript.ibcp.fr/
FigTree 1.4.2 N/A http://tree.bio.ed.ac.uk/software/figtree/
GraphPad Prism N/A https://www.graphpad.com/
IUPred2 62,63
MODELLER 9.13 N/A https://salilab.org/modeller/
NMRPipe 87 https://www.ibbr.umd.edu/nmrpipe/
PhyML 88 http://www.atgc-montpellier.fr/phyml/
PLUMED 2.4.4 89 https://www.plumed.org/
ProtParam N/A https://web.expasy.org/protparam/
PyEMMA 58 http://emma-project.org/latest/
SigmaPlot N/A https://systatsoftware.com/sigmaplot/
Sparky T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco https://www.cgl.ucsf.edu/home/sparky/
VMD 81 http://www.ks.uiuc.edu/Research/vmd/

Highlights.

  • Evolutionary conservation of flexibility between functional homologs remains elusive

  • Allosteric control of unique family members is required to achieve target specificity

  • Conformational and biophysical characterization of homologous EARs was performed

  • Profiles within family imply divergence rather than conservation of flexibility

ACKNOWLEDGMENTS

The authors thank Tara Sprules from the Quebec/Eastern Canada High Field NMR Facility (QANUC, McGill University), Sameer Al-Abdul-Wahid from the University of Guelph NMR Centre, and Ewen Lescop from the Institut de Chimie des Substances Naturelles (ICSN, CNRS, Gif-sur-Yvette, France) for their technical assistance and theoretical NMR discussions. We also thank Marie-Christine Groleau and Pr. Eric Déziel from INRS for their precious help with antibacterial assays. T.H. would like to thank Simon Olsson (FU Berlin, Germany) for his introduction to NMR. This work was supported in part by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) under award number RGPIN-2022-04368 (to N.D.) and NIH (NIGMS) grant under award number R01GM105978 (to N.D. and P.K.A.). The authors also acknowledge the support from scholarship, fellowship, and salary award programs, including the NSERC Canada Graduate Scholarships - Doctoral Program (D.N.B.), the Postdoctoral Fellowship of the Fondation Armand-Frappier (C.N.), and the Research Scholar Senior Career Award (number 281993) of the Fonds de Recherche Québec - Santé (FRQS) (N.D.). T.H. acknowledges financial support from Deutsche Forschungsgemeinschaft (SFB/TRR 186, Project A12). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1548562. XSEDE computing allocation was awarded to P.K.A. (MCB-180199 and MCB-190044). No competing financial interests have been declared.

INCLUSION AND DIVERSITY

One or more of the authors of this paper self-identifies as a member of the LGBTQIA+ community. We support inclusive, diverse, and equitable conduct of research.

Footnotes

DECLARATION OF INTERESTS

Pratul K. Agarwal is the founder of the company Arium BioLabs, LLC.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  • 1.Agarwal PK (2019). A Biophysical Perspective on Enzyme Catalysis. Biochemistry 58, 438–449. 10.1021/acs.biochem.8b01004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Frauenfelder H, Parak F, and Young RD (1988). Conformational substates in proteins. Annu Rev Biophys Biophys Chem 17, 451–479. 10.1146/annurev.bb.17.060188.002315. [DOI] [PubMed] [Google Scholar]
  • 3.Henzler-Wildman K, and Kern D (2007). Dynamic personalities of proteins. Nature 450, 964–972. 10.1038/nature06522. [DOI] [PubMed] [Google Scholar]
  • 4.Maria-Solano MA, Serrano-Hervás E, Romero-Rivera A, Iglesias-Fernández J, and Osuna S (2018). Role of conformational dynamics in the evolution of novel enzyme function. Chem Commun (Camb) 54, 6622–6634. 10.1039/c8cc02426j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bhabha G, Biel JT, and Fraser JS (2015). Keep on moving: discovering and perturbing the conformational dynamics of enzymes. Acc Chem Res 48, 423–430. 10.1021/ar5003158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Agarwal PK, Doucet N, Chennubhotla C, Ramanathan A, and Narayanan C (2016). Conformational Sub-states and Populations in Enzyme Catalysis. In Methods in Enzymology (Elsevier; ), pp. 273–297. 10.1016/bs.mie.2016.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bhabha G, Lee J, Ekiert DC, Gam J, Wilson IA, Dyson HJ, Benkovic SJ, and Wright PE (2011). A dynamic knockout reveals that conformational fluctuations influence the chemical step of enzyme catalysis. Science 332, 234–238. 10.1126/science.1198542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fraser JS, Clarkson MW, Degnan SC, Erion R, Kern D, and Alber T (2009). Hidden alternative structures of proline isomerase essential for catalysis. Nature 462, 669–673. 10.1038/nature08615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kovermann M, Grundström C, Sauer-Eriksson AE, Sauer UH, and Wolf-Watz M (2017). Structural basis for ligand binding to an enzyme by a conformational selection pathway. Proc Natl Acad Sci U S A 114, 6298–6303. 10.1073/pnas.1700919114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Narayanan C, Bernard D, and Doucet N (2016). Role of Conformational Motions in Enzyme Function: Selected Methodologies and Case Studies. Catalysts 6, 81. 10.3390/catal6060081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kokkonen P, Bednar D, Dockalova V, Prokop Z, and Damborsky J (2018). Conformational changes allow processing of bulky substrates by a haloalkane dehalogenase with a small and buried active site. J Biol Chem 293, 11505–11512. 10.1074/jbc.RA117.000328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Doucet N, Khirich G, Kovrigin EL, and Loria JP (2011). Alteration of Hydrogen Bonding in the Vicinity of Histidine 48 Disrupts Millisecond Motions in RNase A. Biochemistry 50, 1723–1730. 10.1021/bi1018539. [DOI] [PubMed] [Google Scholar]
  • 13.Gagné D, French RL, Narayanan C, Simonović M, Agarwal PK, and Doucet N (2015). Perturbation of the Conformational Dynamics of an Active-Site Loop Alters Enzyme Activity. Structure 23, 2256–2266. 10.1016/j.str.2015.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kovrigin EL, and Loria JP (2006). Enzyme dynamics along the reaction coordinate: critical role of a conserved residue. Biochemistry 45, 2636–2647. 10.1021/bi0525066. [DOI] [PubMed] [Google Scholar]
  • 15.Raines RT (1998). Ribonuclease A. Chem Rev 98, 1045–1066. 10.1021/cr960427h. [DOI] [PubMed] [Google Scholar]
  • 16.Sorrentino S (2010). The eight human “canonical” ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett 584, 2194–2200. 10.1016/j.febslet.2010.04.018. [DOI] [PubMed] [Google Scholar]
  • 17.Gagné D, and Doucet N (2013). Structural and functional importance of local and global conformational fluctuations in the RNase A superfamily. FEBS J 280, 5596–5607. 10.1111/febs.12371. [DOI] [PubMed] [Google Scholar]
  • 18.Cho S, Beintema JJ, and Zhang J (2005). The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85, 208–220. 10.1016/j.ygeno.2004.10.008. [DOI] [PubMed] [Google Scholar]
  • 19.Boix E, Salazar VA, Torrent M, Pulido D, Nogués MV, and Moussaoui M (2012). Structural determinants of the eosinophil cationic protein antimicrobial activity. Biol Chem 393, 801–815. 10.1515/hsz-2012-0160. [DOI] [PubMed] [Google Scholar]
  • 20.Garnett ER, and Raines RT (2022). Emerging biological functions of ribonuclease 1 and angiogenin. Crit Rev Biochem Mol Biol 57, 244–260. 10.1080/10409238.2021.2004577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Goo SM, and Cho S (2013). The expansion and functional diversification of the mammalian ribonuclease a superfamily epitomizes the efficiency of multigene families at generating biological novelty. Genome Biol Evol 5, 2124–2140. 10.1093/gbe/evt161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Premzl M (2014). Comparative genomic analysis of eutherian ribonuclease A genes. Mol Genet Genomics 289, 161–167. 10.1007/s00438-013-0801-5. [DOI] [PubMed] [Google Scholar]
  • 23.Rosenberg HF, Dyer KD, Tiffany HL, and Gonzalez M (1995). Rapid evolution of a unique family of primate ribonuclease genes. Nat Genet 10, 219–223. 10.1038/ng0695-219. [DOI] [PubMed] [Google Scholar]
  • 24.Zhang J, and Rosenberg HF (2002). Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates. Proc Natl Acad Sci U S A 99, 5486–5491. 10.1073/pnas.072626199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gupta SK, Haigh BJ, Griffin FJ, and Wheeler TT (2013). The mammalian secreted RNases: mechanisms of action in host defence. Innate Immun 19, 86–97. 10.1177/1753425912446955. [DOI] [PubMed] [Google Scholar]
  • 26.Leonidas DD, Shapiro R, Allen SC, Subbarao GV, Veluraja K, and Acharya KR (1999). Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J Mol Biol 285, 1209–1233. 10.1006/jmbi.1998.2378. [DOI] [PubMed] [Google Scholar]
  • 27.Li S, Sheng J, Hu JK, Yu W, Kishikawa H, Hu MG, Shima K, Wu D, Xu Z, Xin W, et al. (2013). Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis 16, 387–404. 10.1007/s10456-012-9322-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lu L, Li J, Moussaoui M, and Boix E (2018). Immune Modulation by Human Secreted RNases at the Extracellular Space. Front Immunol 9, 1012. 10.3389/fimmu.2018.01012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rosenberg HF (1995). Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 270, 7876–7881. 10.1074/jbc.270.14.7876. [DOI] [PubMed] [Google Scholar]
  • 30.Dyer KD, and Rosenberg HF (2006). The RNase a superfamily: Generation of diversity and innate host defense. Mol Divers 10, 585–597. 10.1007/s11030-006-9028-2. [DOI] [PubMed] [Google Scholar]
  • 31.Narayanan C, Gagné D, Reynolds KA, and Doucet N (2017). Conserved amino acid networks modulate discrete functional properties in an enzyme superfamily. Sci Rep 7, 3207. 10.1038/s41598-017-03298-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Narayanan C, Bernard DN, Bafna K, Gagné D, Chennubhotla CS, Doucet N, and Agarwal PK (2018). Conservation of Dynamics Associated with Biological Function in an Enzyme Superfamily. Structure 26, 426–436.e3. 10.1016/j.str.2018.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bedoya VI, Boasso A, Hardy AW, Rybak S, Shearer GM, and Rugeles MT (2006). Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression. AIDS Res Hum Retroviruses 22, 897–907. 10.1089/aid.2006.22.897. [DOI] [PubMed] [Google Scholar]
  • 34.Domachowske JB, Bonville CA, Dyer KD, and Rosenberg HF (1998). Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus. Nucleic Acids Res 26, 5327–5332. 10.1093/nar/26.23.5327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rosenberg HF (2015). Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense. Int J Mol Sci 16, 15442–15455. 10.3390/ijms160715442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Navarro S, Aleu J, Jiménez M, Boix E, Cuchillo CM, and Nogués MV (2008). The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell Mol Life Sci 65, 324–337. 10.1007/s00018-007-7499-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Singh A, and Batra JK (2011). Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein. Biol Chem 392, 337–346. 10.1515/BC.2011.037. [DOI] [PubMed] [Google Scholar]
  • 38.Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, and Gleich GJ (1989). Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 142, 4428–4434. [PubMed] [Google Scholar]
  • 39.Salazar VA, Rubin J, Moussaoui M, Pulido D, Nogués MV, Venge P, and Boix E (2014). Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms. FEBS J 281, 5432–5446. 10.1111/febs.13082. [DOI] [PubMed] [Google Scholar]
  • 40.Rosenberg HF (2008). RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol 83, 1079–1087. 10.1189/jlb.1107725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rosenberg HF, and Dyer KD (1997). Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity. Nucleic Acids Res 25, 3532–3536. 10.1093/nar/25.17.3532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Doucet N, Watt ED, and Loria JP (2009). The flexibility of a distant loop modulates active site motion and product release in ribonuclease A. Biochemistry 48, 7160–7168. 10.1021/bi900830g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gagné D, Charest L-A, Morin S, Kovrigin EL, and Doucet N (2012). Conservation of flexible residue clusters among structural and functional enzyme homologues. J Biol Chem 287, 44289–44300. 10.1074/jbc.M112.394866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Watt ED, Shimada H, Kovrigin EL, and Loria JP (2007). The mechanism of rate-limiting motions in enzyme function. Proc Natl Acad Sci U S A 104, 11981–11986. 10.1073/pnas.0702551104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pizzo E, and D’Alessio G (2007). The success of the RNase scaffold in the advance of biosciences and in evolution. Gene 406, 8–12. 10.1016/j.gene.2007.05.006. [DOI] [PubMed] [Google Scholar]
  • 46.Rosenberg HF, and Domachowske JB (2001). Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70, 691–698. [PubMed] [Google Scholar]
  • 47.Rosenberg HF, and Dyer KD (1995). Eosinophil cationic protein and eosinophil-derived neurotoxin. Evolution of novel function in a primate ribonuclease gene family. J Biol Chem 270, 21539–21544. 10.1074/jbc.270.37.21539. [DOI] [PubMed] [Google Scholar]
  • 48.Torrent M, Pulido D, Nogués MV, and Boix E (2012). Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLoS Pathog 8, e1003005. 10.1371/journal.ppat.1003005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pulido D, Moussaoui M, Andreu D, Nogués MV, Torrent M, and Boix E (2012). Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure. Antimicrob Agents Chemother 56, 2378–2385. 10.1128/AAC.06107-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Attery A, and Batra JK (2017). Mouse eosinophil associated ribonucleases: Mechanism of cytotoxic, antibacterial and antiparasitic activities. Int J Biol Macromol 94, 445–450. 10.1016/j.ijbiomac.2016.10.041. [DOI] [PubMed] [Google Scholar]
  • 51.Cole R, and Loria JP (2002). Evidence for flexibility in the function of ribonuclease A. Biochemistry 41, 6072–6081. 10.1021/bi025655m. [DOI] [PubMed] [Google Scholar]
  • 52.Gagné D, Narayanan C, Bafna K, Charest L-A, Agarwal PK, and Doucet N (2017). Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin. Biomol NMR Assign 11, 143–149. 10.1007/s12104-017-9736-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Gagné D, Narayanan C, Bafna K, Charest L-A, Agarwal PK, and Doucet N (2018). Correction to: Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin. Biomol NMR Assign 12, 365–367. 10.1007/s12104-018-9833-4. [DOI] [PubMed] [Google Scholar]
  • 54.Narayanan C, Bernard DN, Létourneau M, Gagnon J, Gagné D, Bafna K, Calmettes C, Couture J-F, Agarwal PK, and Doucet N (2020). Insights into Structural and Dynamical Changes Experienced by Human RNase 6 upon Ligand Binding. Biochemistry 59, 755–765. 10.1021/acs.biochem.9b00888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Vallurupalli P, Bouvignies G, and Kay LE (2012). Studying “invisible” excited protein states in slow exchange with a major state conformation. J Am Chem Soc 134, 8148–8161. 10.1021/ja3001419. [DOI] [PubMed] [Google Scholar]
  • 56.Vallurupalli P, Sekhar A, Yuwen T, and Kay LE (2017). Probing conformational dynamics in biomolecules via chemical exchange saturation transfer: a primer. J Biomol NMR 67, 243–271. 10.1007/s10858-017-0099-4. [DOI] [PubMed] [Google Scholar]
  • 57.Kempf JG, and Loria JP (2004). Measurement of intermediate exchange phenomena. Methods Mol Biol 278, 185–231. 10.1385/1-59259-809-9:185. [DOI] [PubMed] [Google Scholar]
  • 58.Scherer MK, Trendelkamp-Schroer B, Paul F, Pérez-Hernández G, Hoffmann M, Plattner N, Wehmeyer C, Prinz J-H, and Noé F (2015). PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models. J Chem Theory Comput 11, 5525–5542. 10.1021/acs.jctc.5b00743. [DOI] [PubMed] [Google Scholar]
  • 59.Prinz J-H, Wu H, Sarich M, Keller B, Senne M, Held M, Chodera JD, Schütte C, and Noé F (2011). Markov models of molecular kinetics: generation and validation. J Chem Phys 134, 174105. 10.1063/1.3565032. [DOI] [PubMed] [Google Scholar]
  • 60.Noé F, Doose S, Daidone I, Löllmann M, Sauer M, Chodera JD, and Smith JC (2011). Dynamical fingerprints for probing individual relaxation processes in biomolecular dynamics with simulations and kinetic experiments. Proc Natl Acad Sci U S A 108, 4822–4827. 10.1073/pnas.1004646108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.DeForte S, and Uversky VN (2017). Not an exception to the rule: the functional significance of intrinsically disordered protein regions in enzymes. Mol Biosyst 13, 463–469. 10.1039/c6mb00741d. [DOI] [PubMed] [Google Scholar]
  • 62.Erdős G, and Dosztányi Z (2020). Analyzing Protein Disorder with IUPred2A. Curr Protoc Bioinformatics 70, e99. 10.1002/cpbi.99. [DOI] [PubMed] [Google Scholar]
  • 63.Mészáros B, Erdos G, and Dosztányi Z (2018). IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic Acids Res 46, W329–W337. 10.1093/nar/gky384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Uversky VN (2018). Conserved Functional Dynamics: I Like to Move It, Move It! Structure 26, 371–373. 10.1016/j.str.2018.02.010. [DOI] [PubMed] [Google Scholar]
  • 65.Agarwal PK, Bernard DN, Bafna K, and Doucet N (2020). Enzyme dynamics: Looking beyond a single structure. ChemCatChem 12, 4704–4720. 10.1002/cctc.202000665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Broom A, Rakotoharisoa RV, Thompson MC, Zarifi N, Nguyen E, Mukhametzhanov N, Liu L, Fraser JS, and Chica RA (2020). Ensemble-based enzyme design can recapitulate the effects of laboratory directed evolution in silico. Nat Commun 11, 4808. 10.1038/s41467-020-18619-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Campbell EC, Correy GJ, Mabbitt PD, Buckle AM, Tokuriki N, and Jackson CJ (2018). Laboratory evolution of protein conformational dynamics. Curr Opin Struct Biol 50, 49–57. 10.1016/j.sbi.2017.09.005. [DOI] [PubMed] [Google Scholar]
  • 68.Fang J, Nevin P, Kairys V, Venclovas Č, Engen JR, and Beuning PJ (2014). Conformational analysis of processivity clamps in solution demonstrates that tertiary structure does not correlate with protein dynamics. Structure 22, 572–581. 10.1016/j.str.2014.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Wales TE, and Engen JR (2006). Partial unfolding of diverse SH3 domains on a wide timescale. J Mol Biol 357, 1592–1604. 10.1016/j.jmb.2006.01.075. [DOI] [PubMed] [Google Scholar]
  • 70.Bhabha G, Ekiert DC, Jennewein M, Zmasek CM, Tuttle LM, Kroon G, Dyson HJ, Godzik A, Wilson IA, and Wright PE (2013). Divergent evolution of protein conformational dynamics in dihydrofolate reductase. Nat Struct Mol Biol 20, 1243–1249. 10.1038/nsmb.2676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Narayanan C, Bernard DN, Bafna K, Gagné D, Agarwal PK, and Doucet N (2018). Ligand-Induced Variations in Structural and Dynamical Properties Within an Enzyme Superfamily. Front. Mol. Biosci. 5, 54. 10.3389/fmolb.2018.00054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Tokuriki N, and Tawfik DS (2009). Protein dynamism and evolvability. Science 324, 203–207. 10.1126/science.1169375. [DOI] [PubMed] [Google Scholar]
  • 73.Campbell E, Kaltenbach M, Correy GJ, Carr PD, Porebski BT, Livingstone EK, Afriat-Jurnou L, Buckle AM, Weik M, Hollfelder F, et al. (2016). The role of protein dynamics in the evolution of new enzyme function. Nat Chem Biol 12, 944–950. 10.1038/nchembio.2175. [DOI] [PubMed] [Google Scholar]
  • 74.Clouthier CM, Morin S, Gobeil SMC, Doucet N, Blanchet J, Nguyen E, Gagné SM, and Pelletier JN (2012). Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions. PLoS One 7, e52283. 10.1371/journal.pone.0052283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Dellus-Gur E, Elias M, Caselli E, Prati F, Salverda MLM, de Visser JAGM, Fraser JS, and Tawfik DS (2015). Negative Epistasis and Evolvability in TEM-1 β-Lactamase--The Thin Line between an Enzyme’s Conformational Freedom and Disorder. J Mol Biol 427, 2396–2409. 10.1016/j.jmb.2015.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Gobeil SMC, Ebert MCCJC, Park J, Gagné D, Doucet N, Berghuis AM, Pleiss J, and Pelletier JN (2019). The Structural Dynamics of Engineered β-Lactamases Vary Broadly on Three Timescales yet Sustain Native Function. Sci Rep 9, 6656. 10.1038/s41598-019-42866-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Risso VA, Martinez-Rodriguez S, Candel AM, Krüger DM, Pantoja-Uceda D, Ortega-Muñoz M, Santoyo-Gonzalez F, Gaucher EA, Kamerlin SCL, Bruix M, et al. (2017). De novo active sites for resurrected Precambrian enzymes. Nat Commun 8, 16113. 10.1038/ncomms16113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Tokuriki N, Jackson CJ, Afriat-Jurnou L, Wyganowski KT, Tang R, and Tawfik DS (2012). Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme. Nat Commun 3, 1257. 10.1038/ncomms2246. [DOI] [PubMed] [Google Scholar]
  • 79.Pál C, Papp B, and Lercher MJ (2006). An integrated view of protein evolution. Nat Rev Genet 7, 337–348. 10.1038/nrg1838. [DOI] [PubMed] [Google Scholar]
  • 80.Trendelkamp-Schroer B, Wu H, Paul F, and Noé F (2015). Estimation and uncertainty of reversible Markov models. The Journal of Chemical Physics 143, 174101. 10.1063/1.4934536. [DOI] [PubMed] [Google Scholar]
  • 81.Humphrey W, Dalke A, and Schulten K (1996). VMD: visual molecular dynamics. J Mol Graph 14, 33–38, 27–28. 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
  • 82.Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, and Woods RJ (2005). The Amber biomolecular simulation programs. J Comput Chem 26, 1668–1688. 10.1002/jcc.20290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7, 539. 10.1038/msb.2011.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, and Laue ED (2005). The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687–696. 10.1002/prot.20449. [DOI] [PubMed] [Google Scholar]
  • 85.Roe DR, and Cheatham TE (2013). PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput 9, 3084–3095. 10.1021/ct400341p. [DOI] [PubMed] [Google Scholar]
  • 86.Robert X, and Gouet P (2014). Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42, W320–324. 10.1093/nar/gku316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, and Bax A (1995). NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277–293. 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
  • 88.Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W, and Gascuel O (2010). New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59, 307–321. 10.1093/sysbio/syq010. [DOI] [PubMed] [Google Scholar]
  • 89.Tribello GA, Bonomi M, Branduardi D, Camilloni C, and Bussi G (2014). PLUMED 2: New feathers for an old bird. Computer Physics Communications 185, 604–613. 10.1016/j.cpc.2013.09.018. [DOI] [Google Scholar]
  • 90.Anisimova M, and Gascuel O (2006). Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol 55, 539–552. 10.1080/10635150600755453. [DOI] [PubMed] [Google Scholar]
  • 91.Boix E, Nikolovski Z, Moiseyev GP, Rosenberg HF, Cuchillo CM, and Nogués MV (1999). Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J Biol Chem 274, 15605–15614. 10.1074/jbc.274.22.15605. [DOI] [PubMed] [Google Scholar]
  • 92.Carreras E, Boix E, Rosenberg HF, Cuchillo CM, and Nogués MV (2003). Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry 42, 6636–6644. 10.1021/bi0273011. [DOI] [PubMed] [Google Scholar]
  • 93.Torrent M, de la Torre BG, Nogués VM, Andreu D, and Boix E (2009). Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J 421, 425–434. 10.1042/BJ20082330. [DOI] [PubMed] [Google Scholar]
  • 94.Miles AA, Misra SS, and Irwin JO (1938). The estimation of the bactericidal power of the blood. J Hyg (Lond) 38, 732–749. 10.1017/s002217240001158x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Loria JP, Rance M, and Palmer AG (1999). A Relaxation-Compensated Carr−Purcell−Meiboom−Gill Sequence for Characterizing Chemical Exchange by NMR Spectroscopy. J. Am. Chem. Soc. 121, 2331–2332. 10.1021/ja983961a. [DOI] [Google Scholar]
  • 96.Carver JP, and Richards RE (1972). A general two-site solution for the chemical exchange produced dependence of T2 upon the carr-Purcell pulse separation. Journal of Magnetic Resonance (1969) 6, 89–105. 10.1016/0022-2364(72)90090-X. [DOI] [Google Scholar]
  • 97.Agarwal PK (2004). Cis/trans isomerization in HIV-1 capsid protein catalyzed by cyclophilin A: insights from computational and theoretical studies. Proteins 56, 449–463. 10.1002/prot.20135. [DOI] [PubMed] [Google Scholar]
  • 98.Noé F, Horenko I, Schütte C, and Smith JC (2007). Hierarchical analysis of conformational dynamics in biomolecules: transition networks of metastable states. J Chem Phys 126, 155102. 10.1063/1.2714539. [DOI] [PubMed] [Google Scholar]
  • 99.Schütte C, Fischer A, Huisinga W, and Deuflhard P (1999). A Direct Approach to Conformational Dynamics Based on Hybrid Monte Carlo. Journal of Computational Physics 151, 146–168. 10.1006/jcph.1999.6231. [DOI] [Google Scholar]
  • 100.Swope WC, Pitera JW, and Suits F (2004). Describing Protein Folding Kinetics by Molecular Dynamics Simulations. 1. Theory. J. Phys. Chem. B 108, 6571–6581. 10.1021/jp037421y. [DOI] [Google Scholar]
  • 101.Hempel T, del Razo MJ, Lee CT, Taylor BC, Amaro RE, and Noé F (2021). Independent Markov decomposition: Toward modeling kinetics of biomolecular complexes. Proc. Natl. Acad. Sci. U.S.A. 118, e2105230118. 10.1073/pnas.2105230118. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data Availability Statement

All NMR chemical shift assignments for MfR3, PpR3, PaR3, and AtR2, including Cα and Cβ resonances, were deposited in the in the Biological Magnetic Resonance Bank (BMRB) (http://www.bmrb.wisc.edu) under accession numbers 27542, 27544, 27545, and 27546, respectively.

This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

RESOURCES